NEW YORK, NY, Authorea, the fastest growing science collaboration and publishing platform, announced that it has closed a $1.5 million financing to deliver valuable new tools to scholars and researchers across the world.
The financing was led by Lux Capital, a venture firm that invests specifically in counter-conventional science & technology companies, along with the Knight Foundation, a non-profit foundation dedicated to supporting transformational ideas that foster informed and engaged communities. Earlier seed investors ff Venture Capital and New York Angels also participated in the round.
Authorea.com is the leading collaboration platform to write, share, and discuss research - all in real-time. It was created in 2013 by Dr. Alberto Pepe, a Harvard astrophysicist, and Dr. Nathan Jenkins, a UC Berkeley physicist, who met while working at CERN and were disappointed by the slow, inefficient, and obsolete ways by which research papers are written and disseminated.
Authorea is currently used by more than 80,000 scholars across 70 countries, in fields as diverse as physics, astronomy and computer science. The company offers users a collaborative online editing platform tailored for academic and technical writing - a word processor, which makes adding citations and equations and formatting references incredibly simple. Authorea is built on a Github-style model and every document created is a Git repository. This allows users to track changes in documents in a very granular way and to easily integrate data into documents.
'We're extremely excited to welcome Lux Capital and the Knight Foundation as new investors,' said Authorea co-founder Dr. Pepe. 'Both have strong reputations and excellent track records in backing transformational companies in science and technology.'
'All economic growth depends on new discoveries, which depend on science,' said Adam Goulburn, PhD, Partner at Lux Capital and Authorea Board member. 'Authorea is taking on the science of science itself - how it's researched, reviewed, produced, and published. Whether taking on the crisis of reproducibility or shortening the time from discovery to market, Authorea is an indispensable tool spanning breakthroughs from the cosmos to cancer.'
'The future of science rests on powerful methods for collaborating on open and reproducible research - Authorea is leading the way to make this happen,' said Sam Arbesman, PhD, Scientist in Residence at Lux. 'What Github did for software developers, Authorea is doing for scientists. Forget stale research stuck in static journals, Authorea catalyzes real-time collaborations and sparks curiosity and creativity in the scientific method. Whether powerfully handling formulas, figures, comments, research results or references - it is a game-changer and competitive edge for any scientist.'
Authorea is rapidly growing in fields outside of the hard sciences, such as genomics, environmental science, and computational biology. For example, in June 2015, a dedicated global team of epidemiology researchers began an ambitious project to track the Ebola virus using large-scale genome sequencing. Their groundbreaking research, written on Authorea, was published in the journal Cell and covered by the New York Times. The Authorea version of their article is the only place where readers can peruse the history, workflows, and research data connected with the study. Authorea is poised to shake up the stale academic publishing industry via an online platform that encourages data sharing, and a more open and transparent dissemination of research results complete with all the data sources necessary to reproduce them. Authorea plans to use the proceeds of this funding to encourage more open, data-driven research of this kind.
Authorea is an online word processor that makes research writing and publishing faster and easier. With more than 80,000 members and a weekly growth rate that has doubled in the past nine months, Authorea is currently the fastest-growing science publishing platform in the world. For more, visit www.authorea.com.
About Lux Capital:
Lux Capital is a venture firm based in New York City and Silicon Valley investing in counter-conventional, seed and early stage science and technology ventures. The firm manages $700 million in assets across four funds. For more information, please see www.luxcapital.com. Follow Lux on Twitter @Lux_Capital.
About Knight Foundation:
Knight Foundation supports transformational ideas that promote quality journalism, advance media innovation, engage communities and foster the arts. The foundation believes that democracy thrives when people and communities are informed and engaged. For more, visit www.knightfoundation.org.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about